founded 1965 headquarters holbaek denmark key people axel kierkegaard chairman of the board lars christensen president and ceo products monofer cosmofer uniferon pharmacosmos dextrans number of employees 130 2016 website www.pharmacosmos.com pharmacosmos is considered a world leading authority in treatment of iron deficiency anaemia . the privately owned specialty pharmaceutical company established in 1965 in holbaek outside copenhagen denmark markets its human and veterinary medicines in a large number of markets throughout the world . the company s brands are monofer cosmofer and uniferon . pharmacosmos maintains an intensive research and development programme targeting iron deficiency therapies and improvement of treatment options . the company is also a world leader in manufacturing of carbohydrate polymers and iron carbohydrate complexes an expert in dextran fractionation techniques and supplies clinical grade dextran fractions complying with the major pharmacopoeias ep usp and jp . pharmacosmos employs 125 people in scandinavia and the uk . contents 1 company profile 1.1 operations 1.2 manufacturing facilities 1.3 research and development 2 products 2.1 monofer 2.2 cosmofer 2.3 uniferon 2.4 dextrans 3 see also 4 references 5 external links company profile edit pharmacosmos was founded in denmark in 1965 by henry marinus christensen m.d. ph.d. operations edit pharmacosmos corporate headquarters manufacturing facilities and research laboratories are located in holbaek denmark scandinavia . the company has its own marketing sales and services operations in denmark and united kingdom . 1 in other geographies the company partners with other pharmaceutical companies responsible for local marketing sales and distribution of its pharmaceuticals brands . the company does not disclose its revenues . manufacturing facilities edit pharmacosmos manufacturing facility is approved according to current good manufacturing practice gmp by the european medicines agency ema and by the u.s. food and drug administration fda . research and development edit the company has an ongoing clinical development program aimed at improving treatment options for patients suffering from iron deficiency anemia . in 2010 pharmacosmos clinical program included three international clinical studies focused on treatment of iron deficiency anemic patients within nephrology gastroenterology and hematology oncology . 2 3 4 products edit monofer edit monofer is a treatment for iron deficiency anemia . the generic name of monofer is iron isomaltoside 1000 developed by pharmacosmos . monofer was approved in december 2009 in 22 european countries for treatment of iron deficiency anemia in patients with varying underlying conditions . 5 6 monofer is approved with a wide dose range and no test dose requirement allowing iron repletion in a single iv dose if a total dose infusion is given in certain clinical situations . 7 this has to be given in a hospital due to increased risks of reaction . if the patient requires a dose over 20 mg kg of idealised body weight a second dose has to be given after waiting a week . 8 cosmofer edit cosmofer is a treatment for iron deficiency anemia . the generic name of cosmofer is low molecular weight iron dextran . cosmofer was approved in 2001 and is available in more than 45 countries worldwide . it has a lower incidence of dextran induced analphylaxis than older dextran based products although still requires a test dose . 9 uniferon edit uniferon is treatment and prevention of iron deficiency anemia in animals . the generic name for uniferon is iron dextran . its approved by health authorities in europe asia and in the u.s. by food and drug administration fda . dextrans edit pharmacosmos is one of the world leaders within production and fractionation of carbohydrates in particular dextran . pharmacosmos has an unique water based technology and production platform for polymer fractioning and derivative synthesis . see also edit list of danish companies list of pharmaceutical companies references edit pharmacosmos establishes uk subsidiary after merger with vitaline pharmaceuticals uk ltd. . pharmacosmos.com . retrieved 2010 08 01 . clinicaltrials.gov identifier no . nct01102413 clinicaltrials.gov identifier no . nct01017614 clinicaltrials.gov identifier no . nct01145638 sinha s. ; kalra p. 2010 . treating the anemic oncology patient with intravenous iron why when and how pdf . european journal of clinical & medical oncology . san lucas medical . 2 1 113 . pharmacosmos monofer receives approval for treatment of iron deficiency anemia . pharmacosmos.com . retrieved 2010 02 20 . medscape medical new iron preparation allows iron repletion in single iv dose . medscape.com . retrieved 2010 08 18 . http www.medicines.org.uk emc medicine 23669 posology http www.medicines.org.uk emc medicine 14139 spc cosmofer posology external links edit pharmacosmos website monofer iron isomaltoside 1000 website cosmofer low mw iron dextran website uniferon iron dextran website pharmacosmos dextran website retrieved from https en.wikipedia.org w index.php title pharmacosmos & oldid 709497803 categories pharmaceutical companies of denmarkveterinary medicine companies navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages dansk edit links this page was last modified on 11 march 2016 at 07 52 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view